Vascular Access Device Market by Type, Route of Insertion, Application, End User - Global Forecast to 2031
Dublin, Sept. 18, 2026 (GLOBE NEWSWIRE) -- "Vascular Access Device Market by Type, Route of Insertion, Application, End User - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering.
Vascular Access Device Market to Reach USD 8.68 Billion by 2031, Driven by Rising Demand for Intravenous Therapies
The global vascular access device market is projected to grow from USD 6.27 billion in 2026 to USD 8.68 billion by 2031, registering a compound annual growth rate of 6.7% during the forecast period.
Market growth is being driven by the rising prevalence of chronic diseases, including cancer, cardiovascular disorders, kidney failure, infections, and autoimmune conditions, which frequently require intravenous therapies. Increasing hospital admissions, surgical procedures, chemotherapy sessions, critical care interventions, and emergency services are further supporting demand for reliable vascular access technologies.
Industry developments in safety-engineered devices, antimicrobial coatings, advanced catheter materials, and ultrasound-guided placement are improving clinical outcomes and reducing complications. Greater emphasis on infection prevention, dosing accuracy, patient safety, and needlestick injury reduction is also accelerating adoption. Additional growth factors include an expanding elderly population, increased use of vascular access devices in pediatric patients, and the continued expansion of ambulatory care, outpatient infusion, and home healthcare services.
Peripheral Vascular Access Devices Expected to Record the Highest CAGR
Based on type, the peripheral vascular access device segment is expected to register the highest CAGR during the forecast period. Growth is supported by increasing demand for short-term intravenous therapy across hospitals, clinics, ambulatory surgical centers, and other medical facilities.
The rising volume of surgical and emergency procedures, combined with greater administration of IV medications and fluids, is strengthening demand for peripheral vascular access devices. These products are widely adopted because of their insertion convenience, cost profile, and comparatively lower risk of severe complications than central access devices. Advancements in catheter materials and engineered safety designs, particularly technologies intended to prevent needlestick injuries, are also supporting segment expansion. The broader transition toward outpatient treatment and more cost-efficient care models is expected to create additional opportunities.
Drug Administration Segment Projected to Grow at the Fastest Rate
By application, drug administration is projected to record the highest CAGR from 2026 to 2031. The segment is benefiting from the increased use of intravenous therapies for cancer, heart disease, infections, autoimmune disorders, and other chronic conditions.
Dependence on IV delivery for chemotherapy, antibiotics, biologics, and pain management continues to rise, supported by rapid therapeutic onset and high bioavailability. Increasing hospital admissions, expanding outpatient infusion center networks, and the adoption of home-based IV therapy are contributing to this growth. Vascular access device innovations that improve dosing accuracy, reduce infection risk, and support long-term drug delivery are expected to reinforce adoption across healthcare settings.
Clinics and Ambulatory Care Centers to Lead End-User Growth
The clinics and ambulatory care centers segment is expected to grow at the highest rate during the forecast period. Healthcare systems are increasingly moving appropriate procedures from inpatient environments to outpatient settings to reduce costs, improve convenience, and shorten recovery times.
The expansion of minimally invasive procedures, infusion therapies, chronic disease management programs, chemotherapy administration, minor surgeries, and same-day operations is increasing the need for safe and efficient vascular access in these facilities. Adoption is also supported by easy-to-use devices with lower complication risks, favorable reimbursement frameworks, rapid procedure turnaround times, and continued growth in stand-alone specialty clinics and ambulatory surgical centers.
Asia Pacific Forecast to Register the Highest Regional CAGR
Asia Pacific is estimated to record the highest CAGR during the forecast period. Regional growth is supported by the expansion of outpatient services and facilities, rising demand for infusion therapies and chemotherapy, and increased management of chronic diseases. Hospitals and patients are increasingly selecting outpatient care because of its cost advantages and reduced inconvenience compared with inpatient treatment.
Technological advancements that enable faster, sterile, and more straightforward device insertion are expected to further strengthen regional adoption. Supportive reimbursement policies, shorter procedure turnaround times, growing use of same-day treatments, and increased deployment of vascular access devices in ambulatory care environments will also contribute to market development.
Competitive Landscape and Leading Market Players
Major companies operating in the vascular access device market include Becton, Dickinson and Company (US), Teleflex Incorporated (US), ICU Medical, Inc. (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Medtronic plc (Ireland), Merit Medical Systems Inc. (US), Terumo Corporation (Japan), Nipro (Japan), Vygon (France), AMECATH (Egypt), Medical Components, Inc. (US), HealthLine Medical Products (US), Cook Medical (US), and Access Vascular, Inc. (US).
Competitive assessment includes market shares, product and service offerings, growth plans, operational capacities, company profiles, product portfolios, and key market strategies. Industry participants are focusing on product enhancement, new launches, research and development, geographic expansion, service improvements, strategic investments, and technologies designed to increase safety and reduce device-related complications.
Research Coverage and Market Opportunities
The report evaluates the vascular access device market and its future growth potential across device and end-user segments. Covered categories include angioplasty stents, endovascular aneurysm repair stent grafts, inferior vena cava filters, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, structural heart devices, and other devices. It also includes a product portfolio matrix for vascular access devices currently available in the market.
The research examines major market drivers, restraints, challenges, and opportunities, including:
The report provides market leaders and new entrants with revenue estimates for the overall vascular access device market and its subsegments. It is designed to help stakeholders assess the competitive environment, identify emerging opportunities, strengthen market positioning, and develop informed go-to-market strategies.
Key Attributes:
Key Topics Covered:
MARKET DYNAMICS
COMPANY PROFILES
For more information about this report visit https://www.researchandmarkets.com/r/ij9uru
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.